Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
A combined Phase 1/Phase 2 trial evaluating mycophenolate mofetil with cyclosporine to reduce graft-versus-host disease in patients undergoi…
-
FDA approval · 2020-01-14FDA Approved: JAKAFI — Supplemental Application (Incyte Corporation)
FDA approved a supplemental application for JAKAFI (ruxolitinib) submitted by Incyte Corporation, resulting in a label change and/or expande…
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating carfilzomib to prevent relapse and graft-versus-host disease in allogeneic stem cell transplant for hema…
-
CLINICAL_TRIALS withdrawal · 2020-01-03Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Leukemia [Phase 3]
A Phase 3 clinical trial evaluating bone marrow transplantation for leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention [Phase 2]
Phase 2 clinical trial update on panobinostat (LBH589) for prevention of acute graft-versus-host disease (aGVHD) after transplant; study com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) [Phase 2]
Phase 2 trial evaluating a steroid-free treatment for standard-risk acute graft-versus-host disease has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections [Phase 4]
Phase 4 clinical trial update reporting pharmacokinetics of posaconazole (Noxafil) when used as prophylaxis for invasive fungal infections i…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD) [EARLY_Phase 1]
Early phase 1 trial investigating extracorporeal photopheresis with methoxsalen for chronic graft-versus-host disease has completed and post…
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT) [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating intravenous administration of RGI-2001 for graft-versus-host disease in patients undergoing allogenic…
-
CLINICAL_TRIALS research · 2019-10-21Clinical Trial Update: Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT)
A completed clinical trial investigating nutrition and outcomes after hematopoietic cell transplantation, including allogeneic stem cell tra…
-
CLINICAL_TRIALS trial_result · 2019-10-17Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 4]
Phase 4 clinical trial update on bone marrow transplantation for hematologic cancers, including conditions such as anemia and graft-versus-h…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT [Phase 1]
Phase 1 dose-finding study of vedolizumab for graft-versus-host disease in participants undergoing allogeneic hematopoietic stem cell transp…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1) [Phase 2]
Phase 2 trial evaluating ruxolitinib in combination with corticosteroids for steroid-refractory acute graft-versus-host disease has complete…
-
CLINICAL_TRIALS trial_result · 2019-08-14Clinical Trial Update: Continuous Alloreactive T Cell Depletion and Regulatory T Cell Expansion for the Treatment of Steroid-refractory or Dependent Chronic GVHD [Phase 2]
Phase 2 clinical trial evaluating continuous alloreactive T cell depletion and regulatory T cell expansion for steroid-refractory or depende…
-
CLINICAL_TRIALS trial_result · 2019-07-11Clinical Trial Update: Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease [Phase 1, Phase 2]
Phase 1/2 study of a Bruton's Tyrosine Kinase inhibitor in subjects with chronic graft-versus-host disease has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) [Phase 2]
Phase 2 dose-finding study assessing vedolizumab for steroid-refractory acute intestinal graft-versus-host disease in patients who underwent…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids [Phase 1, Phase 2]
Phase 1/2 trial investigating early treatment of acute graft-versus-host disease with bone marrow-derived mesenchymal stem cells plus cortic…
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD [Phase 2, Phase 3]
Phase 2/3 trial of GLASSIA for acute graft-versus-host disease (GvHD) was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT [Phase 2]
A Phase 2 clinical trial evaluates low-dose ATG plus low-dose PTCy as graft-versus-host disease prophylaxis in haploidentical hematopoietic …
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Ruxolitinib for Steroid-refractory GVHD [Phase 2]
A Phase 2 clinical trial evaluating ruxolitinib for steroid-refractory graft-versus-host disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease [Phase 2]
Phase 2 trial evaluating infliximab and basiliximab for steroid-refractory acute graft-versus-host disease; study terminated with results po…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) [Phase 3]
A Phase 3 trial evaluating US-ATG-F to prevent chronic graft-versus-host disease in hematologic malignancy patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2019-02-26Clinical Trial Update: Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial investigating rituximab to prevent acute graft-versus-host disease in donor stem cell transplantation for hematologic cancers;…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Vulvovaginal Graft Versus Host Disease (VV-GVHD) in Women Who Underwent Transplantation Before and After Menarche
The clinical trial update reports on a completed study examining vulvovaginal graft-versus-host disease (VV-GVHD) in women who underwent tra…